Minority-Based Community Clinical Oncology Program Groups
Page 2

The MBCCOP Groups will work by providing patients with access to clinical trials in cancer centers, major university centers, and community programs. And in this manner, this access will be realized through another, separately funded, arm of the program called "Research Bases," which are comprised of participating NCI Cooperative Groups and Cancer Centers.

As a result, the linkages that will soon be developed as a result of this access is expected to facilitate the transfer of advances in cancer prevention/control/treatment practices to minority communities and their physicians.

The National Institutes of Health is ready to administer funds in the amount of $5,500,000 to support the Minority-Based Community Clinical Oncology Program Groups.

The institutions and organizations who will be deemed eligible to submit an application under this program are the following:

a) Public and State Controlled Institutions of Higher Education

b) Native American Tribal Governments

c) Federally recognized Native American Tribal Organizations

d) Nonprofit Organizations

e) Private Institutions of Higher Education

f) For-profit organizations

g) Small businesses

The United States Department of Health and Human Services, the mother agency funding the program, is the nation's premiere agency for protecting the health of all Americans and providing essential human services to everyone, especially to those who are medically challenged and financially vulnerable.

Minority-Based Community Clinical Oncology Program Groups
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Clinical Trials for Organ Transplantation in Children Program
The National Insitutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to establish the Clinical Trials for Organ Transplantation in Children Program wherein both agencies intend to support a group of investigators in their quest of conducting clinical trials regarding pediatric solid organ transplant recipients.

---

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research
The National Institutes of Health has formed a partnership with the National Cancer Institute(NCI) in an effort to establish the program entitled Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research.

---